US Market Overview for Orthopedic Biomaterials 2017 - MedView

  • ID: 4085798
  • Report
  • Region: United States
  • 477 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

- Market Drivers & Limiters for each chapter segment

- Competitive Analysis for each chapter segment

- Section on recent mergers & acquisitions

Orthopedic biomaterials are associated with high research and development (R&D) costs, which have subsequently led to premium pricing to recoup these initial costs. This is the case for competitors in the cellular allograft, cell therapy and growth factor segments of the U.S. orthopedic biomaterials market. In particular, orthopedic growth factors have had relatively high average selling prices (ASP) since their introduction to the market due to the high costs of recombinant growth factor technologies. The high R&D costs associated with the growth factor segment provide entry barriers against potential competitors. Currently there are only two growth factor BMP-2 products in the United States. Since they’re both used in different indications, there is a lack of direct competition, allowing companies such as Medtronic to charge a premium for the Spine indication and recover the large initial costs associated with R&D. The commoditized nature in some parts of the market, such as the allograft and DBM segments, which is due to the lack of product differentiation, has limited growth. The market is being driven by more competitors venturing outside their traditional space to tap into the high growth segments where they can charge a premium. These segments may include the cell therapy and cellular allograft segments, both of which have relatively high ASP.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology And Musculoskeletal System
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication For Bone Graft Procedure
2.2.5 Indication For Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. U.S. Orthopedic Biomaterials Market Overview
3.1 Introduction
3.1.1 Bone Graft Substitutes
3.1.2 Growth Factors
3.1.3 Cellular Allograft
3.1.4 Cell Therapies
3.1.5 Hyaluronic Acid Viscosupplementation
3.1.6 Cartilage Repair
3.1.7 Spinal Machined Bone Allografts
3.2 Market Overview
3.3 Trend Analysis By Segment
3.4 Drivers And Limiters
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 Mergers And Acquisitions
3.6 Competitive Market Share Analysis
3.7 Company Profiles
3.7.1 Anika Therapeutics
3.7.2 Bioventus
3.7.3 Depuy Synthes
3.7.4 Ferring Pharmaceuticals
3.7.5 Fidia Pharmaceuticals
3.7.6 Genzyme (Sanofi Group)
3.7.7 Harvest Technologies (Terumo Bct)
3.7.8 Integra Lifesciences
3.7.9 Medtronic
3.7.10 Musculoskeletal Transplant Foundation (Mtf)
3.7.11 Nuvasive
3.7.12 Orthofix
3.7.13 Rti Surgical
3.7.14 Vericel Corporation (Formerly Aastrom Bioscience)
3.7.15 Stryker
3.7.16 Zimmer Biomet

List of Charts

Chart 1 1: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
Chart 3 1: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023
Chart 3 2: Orthopedic Biomaterials Market Breakdown, U.S., 2016
Chart 3 3: Orthopedic Biomaterials Market Breakdown, U.S., 2023
Chart 3 4: Growth Rates By Segment, Orthopedic Biomaterials Market, U.S., 2013 - 2023
Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016

List of Figures

Figure 1 1: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (1 Of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, U.S., 2016
Figure 1 4: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (1 Of 2)
Figure 1 5: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (2 Of 2)
Figure 1 6: Recent Events In The Orthopedic Biomaterials Market, U.S., 2013 - 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 Of 2)
Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 Of 2)
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 Of 3)
Figure 3 1: Total Orthopedic Biomaterials Market, U.S., 2013 - 2023 (Us$M)
Figure 3 2: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023 (Us$M) (1 Of 2)
Figure 3 3: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023 (Us$M) (2 Of 2)
Figure 3 4: Orthopedic Biomaterials Market Growth By Segment, U.S., 2013 - 2023
Figure 3 5: Drivers And Limiters, Orthopedic Biomaterials Market, U.S., 2016
Figure 3 6: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 (1 Of 4)
Figure 3 7: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 (2 Of 4)
Figure 3 8: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 (3 Of 4)
Figure 3 9: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 (4 Of 4)
Figure 5 1: Press Release Summary

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll